Q2 2017 Holdings
Filed 2017-08-11 | 110 holdings | $112.9M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Agios Pharmaceuticals Inc(AGIO) | COM | 00847X104 | $36.0M | 700,000 | 31.9% |
| Biomarin Pharmaceutical Inc(BMRN) | COM | 09061G101 | $22.7M | 250,000 | 20.1% |
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $21.9M | 275,000 | 19.4% |
| Beigene LTD(ONC) | SPONSORED ADR | 07725L102 | $18.0M | 400,000 | 15.9% |
| Biocryst Pharmaceuticals(BCRX) | COM | 09058V103 | $4.7M | 850,000 | 4.2% |
| Cellectis S A(CLLS) | SPONSORED ADS | 15117K103 | $2.6M | 100,000 | 2.3% |
| Blue Buffalo PET Prods Inc | COM | 09531U102 | $2.0M | 87,460,875 | 1.8% |
| Adaptimmune Therapeutics PLC(ADAPY) | SPONSORED ADR | 00653A107 | $1.3M | 300,000 | 1.2% |
| Weight Watchers Intl Inc New | COM | 948626106 | $984.0K | 29,443,300 | 0.9% |
| Lexicon Pharmaceuticals Inc(LXRX) | COM NEW | 528872302 | $946.2K | 57,517,977 | 0.8% |
| Goldman Sachs Group Inc(GS)Call | COM | 38141G104 | $321.8K | 1,450,000 | 0.3% |
| Bank Amer Corp(BAC)Call | COM | 060505104 | $205.0K | 8,450,000 | 0.2% |
| Metlife Inc(MET)Call | COM | 59156R108 | $137.4K | 2,500,000 | 0.1% |
| Gilead Sciences Inc(GILD)Call | COM | 375558103 | $88.5K | 1,250,000 | 0.1% |
| Microsoft Corp(MSFT)Call | COM | 594918104 | $68.9K | 1,000,000 | 0.1% |
| Bristol Myers Squibb Co(BMY)Call | COM | 110122108 | $55.7K | 1,000,000 | 0.0% |
| Incyte Corp(INCY) | COM | 45337C102 | $50.4K | 400,000 | 0.0% |
| Abbvie Inc(ABBV)Call | COM | 00287Y109 | $36.3K | 500,000 | 0.0% |
| Wells Fargo & Co New(WFC)Call | COM | 949746101 | $36.0K | 650,000 | 0.0% |
| Citigroup Inc(C)Call | COM NEW | 172967424 | $33.4K | 500,000 | 0.0% |
| Tesaro IncCall | COM | 881569107 | $32.9K | 235,000 | 0.0% |
| International Business Machs(IBM)Call | COM | 459200101 | $30.8K | 200,000 | 0.0% |
| Nektar Therapeutics(NKTREUR) | COM | 640268108 | $27.4K | 1,400,000 | 0.0% |
| Bluebird BIO Inc | COM | 09609G100 | $26.3K | 250,000 | 0.0% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $25.3K | 550,000 | 0.0% |
| Incyte Corp(INCY)Call | COM | 45337C102 | $25.2K | 200,000 | 0.0% |
| Morgan Stanley(MS)Call | COM NEW | 617446448 | $22.3K | 500,000 | 0.0% |
| Goldman Sachs Group Inc(GS) | COM | 38141G104 | $22.2K | 100,000 | 0.0% |
| Acceleron Pharma Inc(XLRN) | COM | 00434H108 | $21.3K | 700,000 | 0.0% |
| Nektar Therapeutics(NKTREUR)Call | COM | 640268108 | $19.6K | 1,000,000 | 0.0% |
| Teradyne Inc(TER)Call | COM | 880770102 | $15.0K | 500,000 | 0.0% |
| Amicus Therapeutics Inc(FOLD) | COM | 03152W109 | $14.1K | 1,400,000 | 0.0% |
| Biomarin Pharmaceutical Inc(BMRN)Call | COM | 09061G101 | $13.6K | 150,000 | 0.0% |
| Medicines Co | COM | 584688105 | $13.3K | 350,000 | 0.0% |
| Alexion Pharmaceuticals Inc(ALXN) | COM | 015351109 | $12.2K | 100,000 | 0.0% |
| Ironwood Pharmaceuticals Inc(IRWD) | COM CL A | 46333X108 | $11.6K | 616,879 | 0.0% |
| Avexis Inc | COM | 05366U100 | $11.5K | 140,000 | 0.0% |
| Kite Pharma Inc | COM | 49803L109 | $10.4K | 100,000 | 0.0% |
| Athene Hldg LTD | CL A | G0684D107 | $9.9K | 200,000 | 0.0% |
| Ignyta Inc | COM | 451731103 | $9.3K | 900,000 | 0.0% |
| Radius Health IncCall | COM NEW | 750469207 | $9.0K | 200,000 | 0.0% |
| Horizon Pharma PLC | SHS | G4617B105 | $9.0K | 760,000 | 0.0% |
| Array Biopharma Inc(ARRYEUR) | COM | 04269X105 | $8.0K | 950,000 | 0.0% |
| Agenus Inc(AGENEUR) | COM NEW | 00847G705 | $7.8K | 2,000,000 | 0.0% |
| Medicines CoCall | COM | 584688105 | $7.6K | 200,000 | 0.0% |
| Sage Therapeutics Inc(SG7) | COM | 78667J108 | $7.2K | 90,000 | 0.0% |
| Atara Biotherapeutics Inc(ATRAGBX) | COM | 046513107 | $7.0K | 500,000 | 0.0% |
| Tesaro Inc | COM | 881569107 | $7.0K | 50,000 | 0.0% |
| ZTO Express Cayman Inc(ZTO) | SPONSORED ADR | 98980A105 | $7.0K | 500,000 | 0.0% |
| Ionis Pharmaceuticals Inc(IONS) | COM | 462222100 | $6.9K | 135,000 | 0.0% |